News

News from Partners

FMUSP: FMUSP leads the SCImago 2025 Ranking in Latin America

This content is in Portuguese.

28 de março de 2025

News from Partners

Jornal da USP: Comic books help combat misinformation about cancer

This content is in Portuguese.

27 de março de 2025

News from Partners

Jornal da USP: Cell damage process opens doors to melanoma treatment

This content is in Portuguese.

24 de março de 2025

News from Partners

FMRP: FMRP student awarded among the top 25 young scientists in Latin America

This content is in Portuguese.

19 de março de 2025

News from Partners

FMUSP: FMUSP is the best medical school in Latin America, according to the QS World Ranking 2025

This content is in Portuguese.

17 de março de 2025

News from Partners

Icesp: HPV awareness and vaccination event attracts crowd on Avenida Paulista

This content is in Portuguese.

17 de março de 2025

News from Partners

Jornal da USP: In an animal study, aerobic exercise combats tumor growth and improves muscle function.

This content is in Portuguese.

11 de março de 2025

News from Partners

Jornal da USP: USP’s initiatives to improve its research and innovation environment

This content is in Portuguese.

7 de março de 2025

News from Partners

FMRP: Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto becomes a member of the St. Jude Global Alliance

This content is in Portuguese.

27 de fevereiro de 2025

News from Partners

Jornal da USP: Virtual screening reveals new inhibitors of an enzyme related to inflammation and cell proliferation

This content is in Portuguese.

18 de fevereiro de 2025

News from Partners

FMUSP: Researchers from FMUSP present innovative technology in cancer diagnosis in Germany

This content is in Portuguese.

17 de fevereiro de 2025

News from Partners

Jornal da USP: Scientists identify new genetic variant in a family with acute myeloid leukemia

A rare case of hematological cancer was described based on a child and five other family members; genetic testing prevented transplantation and enabled personalized treatment with remission.

10 de fevereiro de 2025